WHC is still in active development. Read this to understand our approach.
depiction of NGBBVGZWCFBOGO-UHFFFAOYSA-N.svg
tripsit

mda

Check on tripsit

psychonaut

MDA

Check on psychonaut

isomerdesign

MDA

Check on isomerdesign

pubchem

Tenamfetamine

Check on pubchem

drugmap

Methylenedioxyamphet...

Check on drugmap

wiki

3,4-Methylenedioxyam...

Check on wiki

Data

InChI: InChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3

Synonyms: Amphedoxamine,AI3-24882, 1,3-Benzodioxole-5-ethanamine, alpha-methyl-, Tenamfetamina [Spanish], BRN 0150196,NCGC00168264-01,DEA No. 7400,EA-1299,SKF-5,1-(3,4-Methylenedioxyphenyl)-2-propylamine, Methylenedioxyamphetamine,.alpha.-Methyl-3,4-methylenedioxyphenethylamine, 4764-17-4,(+/-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,1,3-Benzodioxole-5-ethanamine, alpha-methyl-,(+/-)-.ALPHA.-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE,1-(benzo[d][1,3]dioxol-5-yl)propan-2-amine,UNII-XJZ28FJ27W,DivK1c_000964,Tenamfetamine,1-(2H-1,3-benzodioxol-5-yl)propan-2-amine,CHEBI:166520,NINDS_000964,MDA,AKOS002433952,Tenamfetamine [INN],FT-0739487,(+/-)-MDA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,Tenamfetamina,3,4-Methylenedioxyamphetamine,(S)-(+)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine,IDI1_000964,PDSP1_001410,3-(1,3-benzodioxol-5-yl)-1,1,1,2,3-pentadeuteriopropan-2-amine, 3,4-methylenedioxyamphetamine,1,3-Benzodioxole-5-ethanamine, alpha-methyl- (9CI),Tenamfetamina [Spanish], 1-(1,3-benzodioxol-5-yl)propan-2-amine, 3,4-Methylenedioxy-amphetamine,(-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,MDA (PSYCHEDELIC),3,4-Methylenedioxyamphetamine (MDA),MDA (pharmaceutical),Tenamfetaminum,(?)-alpha-Methyl-1,3-benzodioxole-5-(ethanamine),PDSP2_001394,4764-17-4,(R,S)-3,4-Methylenedioxyamphetamine,DB01509, MDA (pharmaceutical),DTXSID40859958,MDA, (R,S),1-(1,3-benzodioxol-5-yl)propan-2-amine, 5-19-08-00417 (Beilstein Handbook Reference),XJZ28FJ27W,(+)-alpha-Methyl-1,3-benzodioxole-5-(ethanamine),EA-1298,Love,TENAMFETAMINE [MART.],3,4-MDA,1,3-Benzodioxole,5-ethanamine-.alpha.-methyl-(.+/-.),Phenethylamine, .alpha.-methyl-3,4-(methylenedioxy)-,CHEMBL6731,DS-015925,SCHEMBL393456, Tenamfetamine [INN], ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE,BDBM50005247,(+/-)-3,4-(Methylenedioxy)amphetamine,BRN 0150196,MDA,R(-), alpha-Methyl-1,3-benzodioxole-5-ethanamine,MDA [MI], Phenethylamine, alp,rac-MDA (rac-3,4-Methylenedioxyamphetamine) 1.0 mg/ml in Methanol,5-19-08-00417 (Beilstein Handbook Reference), DEA No. 7400,(R)-(-)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,Phenethylamine, alpha-methyl-3,4-(methylenedioxy)-, AI3-24882,2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine,alpha-Methyl-3,4-methylenedioxyphenethylamine,ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE,TENAMFETAMINE [WHO-DD],2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine((R)-(-)-MDA),Methylenedioxyamphetamine,alpha-Methyl-1,3-benzodioxole-5-ethanamine,DL-alpha-Methyl-3,4-(methylenedioxy)phenylethylamine,.alpha.-Methyl-3,4-(methylenedioxy)phenethylamine, CHEMBL6731,51497-09-7,rac-3,4-Methylenedioxyamphetamine,3,4-Methylenedioxy-amphetamine,HSDB 7593,1-Benzo[1,3]dioxol-5-ylpropan-2-amine,methylene dioxyamphetamine,KBio1_000964, Tenamfetaminum [Latin],5-(2-Aminopropyl)-1,3-benzodioxole,1,3-Benzodioxole-5-ethanamine, .alpha.-methyl-,3,4-(Methylenedioxy)-alpha-methylphenylethylamine,3,4-methylenedioxyamphetamine, NGBBVGZWCFBOGO-UHFFFAOYSA-N,Q223020,Tenamfetaminum [Latin]


Estimated data

Solubility: -1.476 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 94.1% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.